Expert Opinion on Investigational Drugs, 23(11), 14771483.
Current pharmacological options do not account for patient-specific variables such as gut microbiome composition, genetic predispositions, or neurobehavioral traits, which may impact therapeutic responsiveness [21, 33]
These include lubiprostone, tenapanor, linaclotide, and plecanatide for IBS-C 5 , and rifaximin, eluxadoline, and alosetron for IBS-D 6,7,8
About SELECT clinical study SELECT (Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity) is a randomised, double-blind, parallel-group, placebo-controlled trial designed to evaluate the efficacy of semaglutide 2.4 mg versus placebo as an adjunct to standard of care for the prevention of major adverse cardiac events (MACE) in people with overweight or obesity and established cardiovascular disease with no prior history of diabetes
Having named compounding pharmacies and listed healthcare providers shows that the platform is committed to quality, despite having a relatively short company history
There are melanophages (secondary to pigment incontinence) in superficial dermis
